바이러스 제거 서비스 : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)
Viral Clearance Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
상품코드:1862242
리서치사:QYResearch
발행일:2025년 10월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 바이러스 제거 서비스 시장 규모는 2024년에 5억 7,200만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 16.5%로 성장하며, 2031년까지 16억 6,700만 달러로 확대할 것으로 예측되고 있습니다.
바이러스 제거 서비스란 바이러스 제거 또는 비활성화 서비스를 말합니다. 바이러스 제거 시험은 생물제제에서 허용 가능한 수준의 바이러스 안전성을 확보하기 위한 중요한 요소입니다. 이 시험의 목적은 제조 및 정제 공정이 원료를 오염시키는 것으로 알려져 있거나 오염시킬 수 있는 바이러스 및 다양한 바이러스의 모델이 될 수 있는 추가 바이러스를 비활성화 및/또는 제거할 수 있는 능력을 입증하는 것입니다. 바이러스 제거 테스트는 제품을 오염시킬 수 있는 모든 바이러스를 검출할 수 없는 세포은행, 원료, 바이오리액터 수확물에 대한 직접 테스트를 보완하는 전략을 제공합니다.
바이러스 제거 서비스 시장은 주로 세계 바이오 제약 산업의 급속한 성장과 제품 안전 및 규정 준수에 대한 규제 요건의 강화에 의해 주도되고 있습니다. 모노클로널 항체, 재조합 단백질, 세포치료제, 유전자치료제 등 생물제제의 보급과 함께 제조 과정에서의 바이러스 오염 위험은 규제 당국의 중요한 관심사로 떠오르고 있으며, 강력한 바이러스 제거 검증 서비스에 대한 수요가 증가하고 있습니다. 임상시험 승인 및 제품 상용화를 목표로 하는 바이오제약 기업은 FDA, EMA 등 규제 당국의 엄격한 기준을 충족하기 위해 종합적인 바이러스 제거 데이터를 제출해야 하며, 이러한 서비스는 제품 개발 파이프라인에서 필수적인 요소입니다. 또한 CDMO(위탁개발제조기관)와 CRO(위탁연구기관)의 등장으로 바이러스 제거 시험의 외주화가 가속화되면서 기업은 개발 효율을 높이고 규제 준수를 확보할 수 있게 되었습니다. 세계 바이오의약품 공급망의 통합이 진행되고 기술 발전으로 바이러스 검출 및 제거 방법의 민감도와 신뢰성이 지속적으로 향상됨에 따라 바이러스 제거 서비스 시장은 견고하고 지속적인 성장을 유지할 것으로 예측됩니다.
북미는 바이러스 제거 서비스 시장에서 가장 큰 규모로 약 51% 시장 점유율을 차지하고 있습니다. 그 뒤를 이어 유럽이 약 23% 시장 점유율을 차지하고 있습니다. 주요 제조업체로는 Charles River, BioReliance(Merck), Eurofins Scientific, Sartorius, Covance, ViruSure, Texcell, Bioscience Labs, Vironova Biosafety, Merieux NutriSciences, WuXi AppTec, Syngene, Labor Dr. Merk 등을 들 수 있습니다. 상위 3개사가 약 39% 시장 점유율을 차지하고 있습니다.
이 보고서는 바이러스 제거 서비스 세계 시장에 대해 총매출액, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고, 지역/국가별, 용도별, 최종사용자별 분석을 종합적으로 제시하는 것을 목적으로 합니다.
바이러스 제거 서비스 시장 규모, 추정 및 예측은 2024년을 기준 연도로 하여 2020-2031년의 기간의 과거 데이터와 예측 데이터를 포함하는 매출액으로 제공되었습니다. 정량적 분석과 정성적 분석을 통해 독자들이 비즈니스/성장 전략을 수립하고, 시장 경쟁 구도를 평가하고, 현재 시장에서의 포지셔닝을 분석하고, 바이러스 제거 서비스에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 돕습니다.
시장 세분화
기업별
Charles River
Sigma-Aldrich(Merck)
Eurofins Scientific
Sartorius
Labcorp
ViruSure
Texcell
Bioscience Labs
QuTEM
Merieux NutriSciences
WuXi AppTec
Syngene
Boehringer Ingelheim
Sino Biological
Creative Biogene
용도별 부문
의약품 용
바이오의약품 용
의료기기 용
최종사용자별 부문
연구기관
제약 업계
기타
지역별
북미
미국
캐나다
아시아태평양
중국
일본
한국
동남아시아
인도
호주
기타 아시아태평양
유럽
독일
프랑스
영국
이탈리아
네덜란드
북유럽 국가
기타 유럽
라틴아메리카
멕시코
브라질
기타 라틴아메리카
중동 및 아프리카
튀르키예
사우디아라비아
아랍에미리트
기타 중동 및 아프리카
KSA
영문 목차
영문목차
The global market for Viral Clearance Service was estimated to be worth US$ 572 million in 2024 and is forecast to a readjusted size of US$ 1667 million by 2031 with a CAGR of 16.5% during the forecast period 2025-2031.
Viral clearance services refer to viral removal or viral inactivation service. Viral clearance studies are a critical element toward ensuring that an acceptable level of viral safety has been achieved for biological products. The goal of these studies is to demonstrate that the manufacturing purification process has the ability to inactivate and/or remove viruses that are known to contaminate or which may possibly contaminate the starting materials, as well as additional viruses that are models for a broad variety of viruses. Viral clearance studies provide a complementary strategy to direct testing of cell banks, raw materials and bioreactor harvests, which may not detect all viruses that could potentially contaminate the product.
The viral clearance service market is primarily driven by the rapid growth of the global biopharmaceutical industry and increasingly stringent regulatory requirements for product safety and compliance. With the widespread adoption of biologics such as monoclonal antibodies, recombinant proteins, cell therapies, and gene therapies, the risk of viral contamination during production has become a critical concern for regulatory agencies, fueling demand for robust viral clearance validation services. Biopharmaceutical companies seeking clinical trial approval or product commercialization are required to submit comprehensive viral clearance data to meet the stringent standards of regulatory bodies like the FDA, EMA, and others, making these services essential to product development pipelines. Additionally, the rise of CDMOs (Contract Development and Manufacturing Organizations) and CROs (Contract Research Organizations) has accelerated the outsourcing of viral clearance testing, allowing companies to improve development efficiency and ensure regulatory compliance. As the global biopharma supply chain becomes more integrated and technological advancements continue to enhance the sensitivity and reliability of viral detection and removal methods, the viral clearance service market is expected to maintain strong and sustained growth.
North America is the largest Viral Clearance Service market with about 51% market share. Europe is follower, accounting for about 23% market share.The key manufacturers are Charles River, BioReliance (Merck), Eurofins Scientific, Sartorius, Covance, ViruSure, Texcell, Bioscience Labs, Vironova Biosafety, Merieux NutriSciences, WuXi AppTec, Syngene, Labor Dr. Merk etc. Top 3 companies occupied about 39% market share.
This report aims to provide a comprehensive presentation of the global market for Viral Clearance Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Viral Clearance Service by region & country, by Application, and by End User.
The Viral Clearance Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Clearance Service.
Market Segmentation
By Company
Charles River
Sigma-Aldrich (Merck)
Eurofins Scientific
Sartorius
Labcorp
ViruSure
Texcell
Bioscience Labs
QuTEM
Merieux NutriSciences
WuXi AppTec
Syngene
Boehringer Ingelheim
Sino Biological
Creative Biogene
Segment by Application
For Pharmaceuticals
For Biopharmaceuticals
For Medical Devices
Segment by End User
Research Institution
Pharmaceutical Industry
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Viral Clearance Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Viral Clearance Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Viral Clearance Service in country level. It provides sigmate data by Application, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Viral Clearance Service Product Introduction
1.2 Global Viral Clearance Service Market Size Forecast (2020-2031)
1.3 Viral Clearance Service Market Trends & Drivers
1.3.1 Viral Clearance Service Industry Trends
1.3.2 Viral Clearance Service Market Drivers & Opportunity
1.3.3 Viral Clearance Service Market Challenges
1.3.4 Viral Clearance Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Viral Clearance Service Players Revenue Ranking (2024)
2.2 Global Viral Clearance Service Revenue by Company (2020-2025)
2.3 Key Companies Viral Clearance Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Viral Clearance Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Viral Clearance Service
2.6 Viral Clearance Service Market Competitive Analysis
2.6.1 Viral Clearance Service Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Viral Clearance Service Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Clearance Service as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Application
3.1 Introduction by Application
3.1.1 For Pharmaceuticals
3.1.2 For Biopharmaceuticals
3.1.3 For Medical Devices
3.2 Global Viral Clearance Service Sales Value by Application
3.2.1 Global Viral Clearance Service Sales Value by Application (2020 VS 2024 VS 2031)
3.2.2 Global Viral Clearance Service Sales Value, by Application (2020-2031)
3.2.3 Global Viral Clearance Service Sales Value, by Application (%) (2020-2031)
4 Segmentation by End User
4.1 Introduction by End User
4.1.1 Research Institution
4.1.2 Pharmaceutical Industry
4.1.3 Others
4.2 Global Viral Clearance Service Sales Value by End User
4.2.1 Global Viral Clearance Service Sales Value by End User (2020 VS 2024 VS 2031)
4.2.2 Global Viral Clearance Service Sales Value, by End User (2020-2031)
4.2.3 Global Viral Clearance Service Sales Value, by End User (%) (2020-2031)
5 Segmentation by Region
5.1 Global Viral Clearance Service Sales Value by Region
5.1.1 Global Viral Clearance Service Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Viral Clearance Service Sales Value by Region (2020-2025)
5.1.3 Global Viral Clearance Service Sales Value by Region (2026-2031)
5.1.4 Global Viral Clearance Service Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Viral Clearance Service Sales Value, 2020-2031
5.2.2 North America Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Viral Clearance Service Sales Value, 2020-2031
5.3.2 Europe Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Viral Clearance Service Sales Value, 2020-2031
5.4.2 Asia Pacific Viral Clearance Service Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Viral Clearance Service Sales Value, 2020-2031
5.5.2 South America Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Viral Clearance Service Sales Value, 2020-2031
5.6.2 Middle East & Africa Viral Clearance Service Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Viral Clearance Service Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Viral Clearance Service Sales Value, 2020-2031
6.3 United States
6.3.1 United States Viral Clearance Service Sales Value, 2020-2031
6.3.2 United States Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
6.3.3 United States Viral Clearance Service Sales Value by End User, 2024 VS 2031
6.4 Europe
6.4.1 Europe Viral Clearance Service Sales Value, 2020-2031
6.4.2 Europe Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
6.4.3 Europe Viral Clearance Service Sales Value by End User, 2024 VS 2031
6.5 China
6.5.1 China Viral Clearance Service Sales Value, 2020-2031
6.5.2 China Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
6.5.3 China Viral Clearance Service Sales Value by End User, 2024 VS 2031
6.6 Japan
6.6.1 Japan Viral Clearance Service Sales Value, 2020-2031
6.6.2 Japan Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
6.6.3 Japan Viral Clearance Service Sales Value by End User, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Viral Clearance Service Sales Value, 2020-2031
6.7.2 South Korea Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
6.7.3 South Korea Viral Clearance Service Sales Value by End User, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Viral Clearance Service Sales Value, 2020-2031
6.8.2 Southeast Asia Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
6.8.3 Southeast Asia Viral Clearance Service Sales Value by End User, 2024 VS 2031
6.9 India
6.9.1 India Viral Clearance Service Sales Value, 2020-2031
6.9.2 India Viral Clearance Service Sales Value by Application (%), 2024 VS 2031
6.9.3 India Viral Clearance Service Sales Value by End User, 2024 VS 2031
7 Company Profiles
7.1 Charles River
7.1.1 Charles River Profile
7.1.2 Charles River Main Business
7.1.3 Charles River Viral Clearance Service Products, Services and Solutions
7.1.4 Charles River Viral Clearance Service Revenue (US$ Million) & (2020-2025)
7.1.5 Charles River Recent Developments
7.2 Sigma-Aldrich (Merck)
7.2.1 Sigma-Aldrich (Merck) Profile
7.2.2 Sigma-Aldrich (Merck) Main Business
7.2.3 Sigma-Aldrich (Merck) Viral Clearance Service Products, Services and Solutions
